Gaois

Search direction

Search mode

Filter results

Collections

3 results in 3 documents

  1. #1709140

    Ina theannta sin, ionas go dtabharfaí aghaidh ar an riosca maidir le gabháil rialála, go n-áiritheofaí leanúnachas, agus go neartófaí neamhspleáchas, ba cheart do na Ballstáit breathnú ar theorainn a chur leis an bhféidearthacht sainorduithe cheann an Bhoird nó chomhaltaí an bhoird a athnuachan agus scéim uainíochta iomchuí a bhunú don bhord agus don ardbhainistíocht.

    Furthermore, to address the risk of regulatory capture, ensure continuity and enhance independence, Member States should consider limiting the possibility of renewing the mandates of the head or members of the board and set up an appropriate rotation scheme for the board and the top management.

    Directive (EU) 2018/1972 of the European Parliament and of the Council of 11 December 2018 establishing the European Electronic Communications Code (Recast)Text with EEA relevance.

  2. #2627833

    á chur i bhfáth gur údarás poiblí í an Ghníomhaireacht, in ainneoin go dtagann an chuid is mó dá mhaoiniú ó fhoinsí príobháideacha; ag cur béim ar an bhfíoras go bhfuil an bhraistint maidir le neamhspleáchas agus sláine na Gníomhaireachta ríthábhachtach agus, dá bhrí sin, go bhfuil gá le hardleibhéal trédhearcachta a áirithiú ina cuid gníomhaíochtaí uile chun gabháil rialála a sheachaint agus chun a áirithiú go leanfaidh saoránaigh de mhuinín a bheith acu sa chóras údaraithe margaíochta san Aontas;

    Stresses that despite the majority of its funding coming from private sources, the Agency is a public authority; underlines that the perception of the Agency’s independence and integrity is crucial and that therefore there is a need to ensure a high degree of transparency in all its activities to avoid regulatory capture and ensure citizens maintain their faith in the marketing authorisation system in the Union;

    Resolution (EU) 2022/1765 of the European Parliament of 4 May 2022 with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the European Medicines Agency (EMA) for the financial year 2020

  3. #3049245

    á chur i bhfáth gur údarás poiblí í an Ghníomhaireacht, in ainneoin go dtagann an chuid is mó dá maoiniú ó fhoinsí príobháideacha; á chur i bhfios go láidir go bhfuil muinín an phobail agus ráthaíocht maidir le neamhspleáchas agus sláine na Gníomhaireachta ríthábhachtach agus, dá bhrí sin, gur gá ardleibhéal trédhearcachta a áirithiú trína gníomhaíochtaí uile chun gabháil rialála a sheachaint agus chun a áirithiú go leanfaidh saoránaigh de mhuinín a bheith acu sa chreat dlíthiúil agus rialála cógaisíochta san Aontas;

    Stresses that despite the majority of funding coming from private sources, the Agency is a public authority; underlines that public trust and guarantees of the Agency’s independence and integrity are crucial and therefore a high degree of transparency needs to be ensured through all its activities to avoid regulatory capture and ensure citizens maintain their faith in the pharmaceutical legal and regulatory framework in the Union;

    Resolution (EU) 2023/1896 of the European Parliament of 10 May 2023 with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the European Medicines Agency (EMA) for the financial year 2021